Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Selenium or compound thereof
Reissue Patent
2011-08-23
2011-08-23
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Selenium or compound thereof
C514S005500, C514S021900, C514S547000, C514S556000, C514S557000, C514S558000, C514S561000, C514S562000, C514S706000, C514S824000, C514S825000, C514S836000, C514S885000, C514S905000
Reissue Patent
active
RE042645
ABSTRACT:
Nutritional or therapeutic compositions containing glutamic acid, cystine, glycine and a selenium precursor and methods for their utilization to increase glutathione synthesis and thereby enhance the immune system are described.
REFERENCES:
patent: 5550146 (1996-08-01), Acosta et al.
patent: 5576351 (1996-11-01), Yoshimura et al.
patent: 5719133 (1998-02-01), Schmidl et al.
patent: 6495170 (2002-12-01), Smit et al.
patent: 2001/0048948 (2001-12-01), Crum et al.
patent: 2 292 522 (1996-02-01), None
patent: 2292522 (1996-02-01), None
patent: 2096034 (1997-11-01), None
patent: 98/15614 (1998-04-01), None
Basic Medical Biochemistry, Velker, J. (ed.), Williams & Wilkins, Baltimore, 1996, pp. 598-601.
Martindale The Extra Pharmacopoeia, 30thed., The Pharmaceutical Press, London, 1993, p. 1047.
Considine, D.M. et al. Van Nostrand's Scientific Encyclopedia, 7th ed., Van Nostrand Reinhold, New York, pp. 128-129 (1989).
Derwent abstract 1998-320409; abstracting RU 2096034 (1997).
BIOSIS abstract 2001:509422 (2001).
PubMed Abstract 61. Powell et al. “Restoration of Glutathione Levels in Vascular Smooth Muscle Cells Exposed to High Glucose Conditions.”Free Radic Biol Med.(2001) Nov. 15; 31 (10):1149-1155.
PubMed Abstract 84. Bender et al. “Characterization of Cystine Uptake in Cultured Astrocytes.”Neurochem Int.(2000) Aug.-Sep.; 37 (2-3):269-276.
PubMed Abstract 123. Wang et al. “Hepatic Export of Glutathione and Uptake of Constituent Amino Acids, Glutamate and Cysteine, in Broilers in Vivo.”Poult Sci.(1998) Oct.; 77 (10):1556-1564.
PubMed Abstract 137. Tachi et al. “High Concentration of Glucose Causes Impairment of the Function of the Glutathione Redox Cycle in Human Vascular Smooth Muscle Cells.”FEBS Lett.(1998) Jan. 2; 421 (1):19-22.
PubMed Abstract 139. Kranich et al. “Utilization of Cysteine and Cysteine Precursors for the Synthesis of Glutathione in Astroglial Cultures: Preference for Cystine.”Glia.(1998) Jan.: 22 (1):11-18.
PubMed Abstract 141. Lu, SC. “Regulation of Hepatic Glutathione Synthesis.”Semin Liver Dis.(1998) 18(4):331-343.
PubMed Abstract 143. Knickelbein et al. “Characterization of Multiple Cysteine and Cystine Transporters in Rat Alveolar Type II Cells.”Am J Physiol.(1997) Dec.; 273(6 Pt 1):L1147-1155.
PubMed Abstract 150. Sayato et al. “Selenium Methylation and Toxicity Mechanism of Selenocystine.”Yakugaku Zasshi(1997) Nov.; 117 (10-11):665-672.
PubMed Abstract 159. van Klaveren et al. “Cellular Glutathione Turnover in Vitro, with Emphasis on Type II Pneumocytes.”Eur Respir J.(1997) Jun.; 10(6):1392-1400.
PubMed Abstract 160. Froissard et al. “Role of Glutathione Metabolism in the Glutamate-Induced Programmed Cell Death of Neuronal-Like PC12 Cells.”Eur J Pharmacol.(1997) May 12;326 (1):93-99.
PubMed Abstract 167. Ochi, T. “Arsenic Compound-Induced Increases in Glutathione Levels in Cultured Chinese Hamster V79 Cells and Mechanisms Associated with Changes in Gamma-Glutamylcysteine Synthetase Activity, Cystine Uptake and Utilization of Cysteine.”Arch Toxicol.(1997); 71(12):730-740.
PubMed Abstract 172. Kranich et al. “Different Preferences in the Utilization of Amino Acids for Glutathione Synthesis in Cultured Neurons and Astroglial Cells Derived from Rat Brain.”Neurosci Lett.(1996) Nov. 29; 219 (3):211-214.
PubMed Abstract 173. Pan et al. “Increased Uptake of L-Cysteine and L-Cystine by Nerve Growth Factor in Rat Pheochromocytoma Cells.”Brian Res.(1996) Nov. 18; 740 (1-2):21-26.
PubMed Abstract 177. Mills et al. “Differential Distribution of Free and Bound Glutathione and Cyst(e)ine in Human Blood.”Biochem Pharmacol.(1996) Aug. 9; 52(3):401-406.
PubMed Abstract 186. Sagara et al. “Glutathione Efflux from Cultures Astrocytes.”J Neurochem.(1996) May; 66 (5):1876-1881.
PubMed Abstract 187. Rathbun et al. “Prevention of Acetaminophen- and Naphthalene-Induced Cataract and Glutathione Loss by CySSME.”Invest Ophthalmol Vis Sci.(1996) Apr.; 37 (5):923-929.
PubMed Abstract 193. Deneke et al. “Mechanisms of Use of Extracellular Glutathione by Lung Epithelial Cells and Pulmonary Artery Endothelial Cells.”Am J Respir Cell Mol Biol.(1995) Jun.; 12 (6):662-668.
PubMed Abstract 195. O'Connor et al. “Biosynthesis and Maintenance of GSH in Primary Astrocyte Cultures: Role of L-Cystine and Ascorbate.”Brain Res.(1995) May 22; 680 (1-2):157-163.
PubMed Abstract 214. Cotgreave et al. “A Role for Gamma-Glutamyl Transpeptidase in the Transport of Cystine into Human Endothelial Cells: Relationship to Intracellular Glutathione.”Biochim Biophys Acta.(1994) Jul. 21; 1222 (3):375-382.
PubMed Abstract 231. Sagara et al. “Maintenance of Neuronal Glutathione by Glial Cells.”J Neurochem.(1993) Nov.; 61 (5):1672-1676.
PubMed Abstract 232. Sagara et al. “Cystine Uptake and Glutathione Level in Fetal Brain Cells in Primary Culture and in Suspension.”J Neurochem.(1993) Nov.; 61 (5):1667-1671.
PubMed Abstract 255. Phelps et al. “Elevation of Glutathione Levels in Bovine Pulmonary Artery Endothelial Cells by N-Acetylcysteine.”Am J Respir Cell Mol Biol.(1992) Sep.; 7 (3):293-299.
PubMed Abstract 265. Deneke et al. “Endothelial Cell Cystine Uptake and Glutathione Increase with N,N-bis(2-chloroethyl)-N-Nitrosourea Exposure.”Am J Physiol.(1992) Mar.; 262 (3 Pt 1):L301-304.
PubMed Abstract 266. Brandi et al. “Differential Effect of the Amino Acid Cystine in Cultured Mammalian and Bacterial Cells Exposed to Oxidative Stress.”Mutat Res.(1992) Mar.; 281 (3):157-161.
PubMed Abstract 271. Droge et al. “Modulation of Lymphocyte Functions and Immune Responses by Cysteine and Cysteine Derivatives.”Am J Med.(1991) Sep. 30; 91 (3C):140S-144S.
PubMed Abstract 292. Atzori et al. “Growth-Associated Modifications of Low-Molecular-Weight Thiols and Protein Sulfhydryls in Human Bronchial Fibroblasts.”J Cell Physiol.(1990) Apr.; 143 (1):165-171.
PubMed Abstract 298. Bannai et al. “Induction of Cystine Transport Activity in Human Fibroblasts by Oxygen.”J Biol Chem.(1989) Nov. 5; 264 (31):18480-18484.
PubMed Abstract 309 Wagner, B. “Glutathione in Tetrahymena thermophila.”J Protozool(1989) 36(1):92-5.
PubMed Abstract 314 Siegel, D.A., et al. “Effect of pairing in vitro on the glutathione level of male Schistosoma mansoni.” J Parasitol (1988) 74(4):524-31.
PubMed Abstract 316 Nygaard, M.E., et al. “Sulfhydryl-related reduction of the mitotic inhibition and cell inactivation induced by pyrimidine analogs.” Anticancer Drug Des. (1988) 3(1):15-24.
PubMed Abstract 320 Ishii, T., et al. “Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine.” J. Cell Physiol. (1987) 133(2):330-6.
PubMed Abstract 369 Mickelson, M.N., et al. “Cystine antagonism of the antibacterial action of lactoperoxidase-thiocyanate-hydrogen peroxide onStreptococcus agalactiae.” Appl Environ Microbiol (1984) 47(2):338-42.
PubMed Abstract 372 Orrenius, S., et al. “Turnover and functions of glutathione studied with isolated hepatic and renal cells.” Fed Proc (1983) 42(15):3177-88.
PubMed Abstract 379 Ohmori, H., et al. “Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes. II. A major role of the mixed disulfide between 2-mercaptoethanol and cysteine.” Cell Immunol (1983) 79(1):173-85.
PubMed Abstract 391 Bannai, S., et al. “Adaptive enhancement of cystine and glutamate uptake in human diploid fibroblasts in culture.” Biochim Biophys Acta (1982) 721(1):1-10.
PubMed Abstract 394 Bannai, S., et al. “Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts: effect of glutamate and homocysteate.” J Cell Physiol (1982) 112(2):265-72.
PubMed Abstract 405 Moldeus
Blank Rome LLP
Pak John
LandOfFree
Nutritional or therapeutic compositions and methods to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutritional or therapeutic compositions and methods to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional or therapeutic compositions and methods to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626127